Daniel Donovan
CIK 1934188 · last filed 2026-07-20
Daniel Donovan is a corporate insider who has filed 4 SEC Form 4 insider transactions across 2 companies since 2023. The most recent filing, for INTS, was dated Jul 20, 2026.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
4
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| INTS | Director | — | $4.55 | — | $0 | 3 | 2026-07-20 |
| Panbela Therapeutics, Inc. (PBLA) Delisted | Director | — | $0.01 | — | $0 | 1 | 2023-03-29 |
Recent Filings
4 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-20 | INTS | Grant (A) | — | $0 | EDGAR |
| 2025-05-06 | INTS | Grant (A) | — | $0 | EDGAR |
| 2024-03-07 | INTS | Grant (A) | — | $0 | EDGAR |
| 2023-03-29 | Panbela Therapeutics, Inc. (PBLA) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.